Navigation Links
Latest Pharmaceutical Launch Strategies Demonstrate Growing Importance of Thought Leader Engagement at Market Entry
Date:10/25/2011

CHAPEL HILL, N.C., Oct. 25, 2011 /PRNewswire/ -- While some newly-developed bio-pharmaceutical products thrive upon launch, many more struggle in today's crowded, competitive marketplace.  

In order to differentiate the treatment benefits of their new products, companies must think strategically about clinical and scientific thought leaders, targeting and engaging those who often serve as the gatekeepers to a product's acceptance in the medical community.

In fact, according to "Success Factors and Failure Points in Cardiovascular Product Launches," more than 80% of participating bio-pharmaceutical companies in Cardiology have found that engaging thought leaders in the actual protocol designs for late-Phase clinical trials is a highly effective method for building product and treatment momentum.

In addition, participating companies rate Advisory Boards and Clinical Trial Involvement as the most effective strategies for cultivating a successful environment at launch, according to this primary research conducted by Best Practices, LLC.

The study, which examines the product manufacturers in the Cardiology therapeutic area, provides insights to a critical core set of functions and activities during product launch, such as engagement of thought leaders and education of key stakeholders.

Download a complimentary study summary at http://www.best-in-class.com/dr354.htm that includes best practices drawn from extensive primary research with 44 executives and managers from 38 leading pharmaceutical, biotech and medical device companies.

Other key insights include:

  • Thought leader engagement is a critical success factor across all therapeutic areas. However, key relationship tactics score quite differently across Cardiology, Diabetes and the multi-therapeutic area class.
  • Payers and patient advocacy are becoming more important constituents for educating the market. Importantly, Diabetes and Cardiology accord different relative importance to each of these constituents.

The full 182-page report presents launch leaders' perspectives on the current and future risk levels for an array of pitfall factors that can affect a new product launch.  In all, the study contains more than 750 benchmark metrics and 39 executive narratives from leaders in the industry.

For more information on this study and other recent primary research studies, contact us at 919.403.0251 or at bestpractices@best-in-class.com.

BEST PRACTICES, LLC is a leading benchmarking, consulting and advisory services firm serving biopharmaceutical and medical device companies worldwide. Best Practices, LLC's clients include all the top 10 and 48 of the top 50 global healthcare companies.

The firm conducts primary research and consulting using its comprehensive proprietary benchmarking tools and analysis. The operational insights, findings and analysis form the basis for our Benchmarking Reports, databases and advisory services to support executives in commercial and R&D operations.

Best Practices, LLC believes in the profound principle that organizations can chart a course to superior economic performance by studying the best business practices, operating tactics and winning strategies of world-class companies.


'/>"/>
SOURCE Best Practices, LLC
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Hologic to Host Special Tomosynthesis Symposium and Feature the Latest in Womens Health Technologies at the Journees Francaises de Radiologie (JFR)
2. Latest Health and Wellness In-Car Technology from Ford to be Showcased Oct. 10-13 in San Diego
3. 2011 Medical Innovation Summit to Showcase Latest Innovations in Cardiovascular Care
4. New York Dermatologist Offers the Latest in Pelleve Wrinkle Reduction Technology
5. Contained Medication System Now Keeping Hospitals Compliant With Latest Legislation
6. Ruby+Associates Completes Latest Mercy Health Systems Design-Build Project
7. Top 5 Ways to Get Insider Track on Healthcare, Pharma & Biotech Discoveries & Latest News
8. Latest Information on Obese Patients with Type 2 Diabetes and LAP-BAND System
9. Latest Releases of Elektas XiO Planning and Focal Contouring Systems Designed to Increase Efficiency in Planning Therapy for Patients with Cancer
10. Enzymatics Reports Latest Growth Figures; Confirms Massachusetts Emerging Role as Leading Bio-manufacturing Center
11. Latest Molecular Diagnostics Technology Aids German Hospital in Management of European E. coli Crisis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2017)... , July 10, 2017 The Institute for ... methods, is the recipient of a VITROCELL® inhalation exposure ... International Science Consortium. The device, which is designed to ... expose human lung cells to airborne test materials in ... use the VITROCELL® system for testing combustible tobacco products, ...
(Date:7/6/2017)... division of Diplomat Specialty Infusion Group, is celebrating a decade of empowering ... celebrate its anniversary, ThriveRx recently launched a redesigned website at thriverx.diplomat.is ... to create the best user experience for consumers and health care professionals. ... Diplomat Pharmacy ... "We,ve made several great strides throughout the past 10 years," ...
(Date:7/5/2017)... , July 5, 2017   BioLife Solutions , ... manufacturer and marketer of proprietary clinical grade cell and ... media ("BioLife"), today announced that it has reached ... holder and largest shareholder, to modify its existing credit ... to the modification, WAVI agreed to exchange its existing ...
Breaking Medicine Technology:
(Date:7/21/2017)... ... July 21, 2017 , ... The Margarian Law Firm has filed ... of its ginger ale for allegedly containing no ginger. Dr. Pepper produces the “Canada ... Inc., plaintiff Gegham Margaryan alleges Canada Dry Ginger Ale claims on its bottle that ...
(Date:7/21/2017)... MO (PRWEB) , ... July 21, 2017 , ... “Kids ... knowing how to tie their shoes,” says Suzanne Tucker, Founder of St. Louis-based positive ... Time-In Toolkit, which launches on Kickstarter on Monday, July 21st. , The kit ...
(Date:7/21/2017)... ... July 21, 2017 , ... The ... offer patients improved quality of life five years after injury, according to research ... Meeting in Toronto, Ontario, Canada. The study followed patients for five years following ...
(Date:7/20/2017)... (PRWEB) , ... July 20, 2017 , ... ... of blood and bone marrow cancer that progresses rapidly without treatment. Newly diagnosed ... to reduce the chance of reoccurrence and relapse. With such a challenging ...
(Date:7/20/2017)... New York (PRWEB) , ... July 20, 2017 ... ... has developed a telemedicine platform, in which their iMedSecure™ comes included with each ... both share encrypted live images to remote participants for real-time collaboration and immediate ...
Breaking Medicine News(10 mins):